Definium Therapeutics, Inc. (DFTX) vs Edgewise Therapeutics, Inc. (EWTX)
A side-by-side comparison of Definium Therapeutics, Inc. and Edgewise Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DFTX
Definium Therapeutics, Inc.
$35.21HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
EWTX
Edgewise Therapeutics, Inc.
$39.54HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — DFTX vs EWTX
growth of $100 · dividends reinvested · last 6yDFTX -1.4% (-0.2%/yr)EWTX +34.3% (+5.0%/yr)EWTX compounded faster over this window
DFTX EWTX
DFTX vs EWTX: by the numbers
- •DFTX is the larger company ($4.67B vs $4.25B market cap).
Metrics side by side
Valuation
| Metric | DFTX | EWTX |
|---|---|---|
| P/B ratio | 5.09 | 9.49 |
Profitability
| Metric | DFTX | EWTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -38.51% | -44.02% |
| ROIC | -23.81% | -48.57% |
Growth (annualized)
| Metric | DFTX | EWTX |
|---|---|---|
| Total return CAGR (5Y) | 1.43% | 16.95% |
Frequently asked
- How have DFTX and EWTX total returns compared?
- Over the past 5 years, DFTX delivered 1.43% and EWTX delivered 16.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.